Penumbra (PEN) Raw Materials (2014 - 2026)
Penumbra's (PEN) quarterly Raw Materials came in at $110.2 million in Q1 2026, down 5.61% year-on-year from $116.8 million in Q1 2025, and down 5.86% on a QoQ basis from $117.1 million in Q4 2025.
Penumbra (PEN) Raw Materials (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Raw Materials data on file, last reported at $110.2 million in Q1 2026.
- On a quarterly basis, Raw Materials fell 5.61% year-over-year to $110.2 million in Q1 2026; TTM through Mar 2026 was $110.2 million, a 5.61% decrease from a year earlier, with the FY2025 full-year figure at $117.1 million, down 12.59% from the prior year.
- Raw Materials for Q1 2026 stood at $110.2 million, down from $117.1 million in the prior quarter.
- Over the last five years, Raw Materials for PEN reached as high as $134.0 million in Q4 2024 and fell as low as $73.2 million in Q1 2022.
- Historically, Raw Materials has averaged $108.0 million across 5 years, with a median of $116.3 million in 2025.
- Across the five-year window, Raw Materials soared 33.14% in 2024 and decreased 12.59% in 2025, its largest moves.
- Year by year, Raw Materials stood at $90.8 million in 2022, then jumped by 31.64% to $119.5 million in 2023, then grew by 12.1% to $134.0 million in 2024, then dropped by 12.59% to $117.1 million in 2025, then fell by 5.86% to $110.2 million in 2026.
- Per Business Quant data, the three most recent Raw Materials figures were $110.2 million in Q1 2026, $117.1 million in Q4 2025, and $116.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110.24 Mn |
| Dec 31, 2025 | 117.10 Mn |
| Sep 30, 2025 | 116.30 Mn |
| Jun 30, 2025 | 122.59 Mn |
| Mar 31, 2025 | 116.79 Mn |
| Dec 31, 2024 | 133.97 Mn |
| Sep 30, 2024 | 126.57 Mn |
| Jun 30, 2024 | 125.92 Mn |
| Mar 31, 2024 | 121.13 Mn |
| Dec 31, 2023 | 119.51 Mn |
| Sep 30, 2023 | 110.09 Mn |
| Jun 30, 2023 | 100.17 Mn |
| Mar 31, 2023 | 90.98 Mn |
| Dec 31, 2022 | 90.79 Mn |
| Sep 30, 2022 | 84.91 Mn |
| Jun 30, 2022 | 75.48 Mn |
| Mar 31, 2022 | 73.22 Mn |
| Dec 31, 2021 | 68.37 Mn |
| Sep 30, 2021 | 64.47 Mn |
| Jun 30, 2021 | 64.13 Mn |